Financials
- Market Capitalization 11.36 B
- Employee 3 000
- Founded 1976
- CEO Kim Kelderman
- Website www.bio-techne.com
- Headquarter Minnesota, United States
- FIGI BBG000C15114
- Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
60.91
주가매출액비율
9.13
주당 배당금
0.32
배당수익률 %
0.45
Related tickers
| # | 이름 | 가격 | 24h % | 7d % | 1M % | 1Y % | 마켓 캡 | 이전 7일 | |
|---|---|---|---|---|---|---|---|---|---|
| 757 | BBIO BridgeBio Pharma, Inc. - Common Stock | 65.35 USD | +0.48% | -3.04% | -9.92% | +14.65% | 12.78 B USD | ||
| 774 | HALO Halozyme Therapeutics, Inc. - Common Stock | 110.42 USD | +0.53% | +0.70% | +2.24% | +65.30% | 12.53 B USD | ||
| 834 | IBRX ImmunityBio, Inc. - Common Stock | 10.51 USD | +6.05% | -2.32% | +33.21% | +341.60% | 11.14 B USD | ||
| 847 | MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 471.75 USD | -1.08% | -6.58% | -12.64% | +11.36% | 10.90 B USD |